Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Arkowitz David
Relationship:  
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   417,314    

Indirect Shares

   0      
Direct Value   $2,214,630    

Indirect Value

   $0      
Total Shares   417,314      
Total Value   $2,214,630      


Idenix Pharmaceuticals Inc $0 AMAG Pharmaceuticals Inc $24,833 Flexion Therapeutics Inc $2,012,957 Kineta Ord Shs $2,079 Seres Therapeutics, Inc. $174,761 Idenix Pharmaceuticals Inc $0 AMAG Pharmaceuticals Inc $24,833 Flexion Therapeutics Inc $2,012,957 Kineta Ord Shs $2,079 Seres Therapeutics, Inc. $174,761
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    3    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    3    
   
     Gain/Loss Ratio :
   0.0   
   -3.0   
     Percentage Gain/Loss :
     0.0%
 -191.8%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Idenix Pharmaceuticals Inc IDIX Chief Financial Officer 2004-07-27 8,000 2004-07-27 0    Premium*  
            AMAG Pharmaceuticals Inc AMAG EVP, CFO, CBO 2011-05-31 1,806 2007-12-03 0    Premium*  
            F-star Therapeutics, Inc FSTX Director 2023-03-08 0 2016-11-23 0    Premium*  
            Flexion Therapeutics Inc FLXN Chief Financial Officer 2021-05-10 220,719 2018-06-01 0    Premium*  
            Kineta Ord Shs KA Director 2020-12-22 4,347 2020-12-22 0    Premium*  
            Seres Therapeutics, Inc. MCRB 2024-02-16 182,442 0    Premium*  
* Premium Members only  

Records found :    50         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 2
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
AMAG AMAG Pharmaceuticals Inc CFO and Chief Business Officer   •       –      –    2007-04-29 4 A $0.00 $0 D/D 750 1,056 0 -
AMAG AMAG Pharmaceuticals Inc CFO and Chief Business Officer   •       –      –    2007-05-05 4 B $40.37 $40,378 D/D 1,000 2,056 2.74 -
AMAG AMAG Pharmaceuticals Inc CFO and Chief Business Officer   •       –      –    2007-12-03 4 A $48.99 $14,991 D/D 306 306 0 -
AMAG AMAG Pharmaceuticals Inc CFO & Chief Business Officer   •       –      –    2008-06-02 4 A $34.00 $14,620 D/D 430 2,486 0 -
AMAG AMAG Pharmaceuticals Inc CFO, CBO, and Exec. VP   •       –      –    2008-06-11 4 B $37.50 $37,500 D/D 1,000 3,486 2.74 -
AMAG AMAG Pharmaceuticals Inc CFO and Chief Business Officer   •       –      –    2009-06-02 4 B $25.61 $13,548 D/D 529 4,765 2.74 -
AMAG AMAG Pharmaceuticals Inc EVP, CFO and CBO   •       –      –    2009-08-03 4 A $0.00 $0 D/D 750 4,236 0 -
AMAG AMAG Pharmaceuticals Inc CFO and Chief Business Officer   •       –      –    2009-11-12 4 S $43.42 $193,587 D/D (4,459) 306 0 -
AMAG AMAG Pharmaceuticals Inc CFO and Chief Business Officer   •       –      –    2009-12-01 4 B $31.78 $5,466 D/D 172 478 2.74 -
AMAG AMAG Pharmaceuticals Inc EVP, CFO and CBO   •       –      –    2010-04-30 4 A $0.00 $0 D/D 750 1,228 0 -
AMAG AMAG Pharmaceuticals Inc EVP, CFO and CBO   •       –      –    2010-05-28 4 B $27.06 $17,805 D/D 658 1,886 2.74 -
AMAG AMAG Pharmaceuticals Inc EVP, CFO and CBO   •       –      –    2010-08-05 4 AS $0.00 $0 D/D (15,750) 1,136 0 -
AMAG AMAG Pharmaceuticals Inc EVP, CFO and CBO   •       –      –    2010-08-05 4 A $0.00 $0 D/D 15,000 16,886 0 -
AMAG AMAG Pharmaceuticals Inc EVP, Chief Financial Officer   •       –      –    2011-02-24 4 A $0.00 $0 D/D 1,875 3,011 0 -
AMAG AMAG Pharmaceuticals Inc EVP, Chief Financial Officer   •       –      –    2011-02-24 4 AS $17.06 $46,167 D/D (2,705) 306 0 -
AMAG AMAG Pharmaceuticals Inc EVP, CFO and CBO   •       –      –    2011-05-31 4 B $13.23 $19,845 D/D 1,500 1,806 2.74 -
FLXN Flexion Therapeutics Inc Chief Financial Officer   •       –      –    2018-06-01 4 A $0.00 $0 D/D 30,000 40,250 0 -
FLXN Flexion Therapeutics Inc Chief Financial Officer   •       –      –    2018-08-09 4 B $23.42 $93,680 D/D 4,000 44,250 2.74 -
FLXN Flexion Therapeutics Inc Chief Financial Officer   •       –      –    2018-11-09 4 B $16.56 $66,222 D/D 4,000 48,250 2.74 -
FLXN Flexion Therapeutics Inc Chief Financial Officer   •       –      –    2018-12-20 4 A $10.48 $9,663 D/D 922 49,172 0 -
FLXN Flexion Therapeutics Inc Chief Financial Officer   •       –      –    2019-03-01 4 A $0.00 $0 D/D 36,000 85,172 0 -
FLXN Flexion Therapeutics Inc Chief Financial Officer   •       –      –    2019-05-08 4 AS $10.06 $22,615 D/D (2,248) 82,924 0 -
FLXN Flexion Therapeutics Inc Chief Financial Officer   •       –      –    2019-05-31 4 B $11.05 $27,627 D/D 2,500 89,424 2.74 -
FLXN Flexion Therapeutics Inc Chief Financial Officer   •       –      –    2019-06-21 4 A $9.81 $21,111 D/D 2,152 91,576 0 -
FLXN Flexion Therapeutics Inc Chief Financial Officer   •       –      –    2020-01-03 4 S $0.00 $0 D/D (3,095) 88,481 0 %
  50  Records found
  1  2      
  Page 1 of 2  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us